Program Overview

Ethics and Good Practice for Medicines (7BBP0013)

Course Overview

This module provides training over five days on the concepts of ethics, good practice and risk/benefit in the development and marketing of medicines. It introduces the principles of ethics before focusing on ethical practice and the regulation of these practices.

Course Details

• Duration: 5 days
• Delivery mode: In person
• Application deadline: 10 August 2025
• Places: Available

Course Features

This course covers typical issues of ethics that arise in biomedical research and pharmaceutical medicine such as the clinical development of medicines and the commercialisation of medicines. A significant proportion of the time in this 5-day module will be devoted to discussions and workshops.

Course Content

This module aims to:

• Enable students to critically assess the ethical principles and frameworks that impact upon the development and marketing of medicines.
• Give students an in-depth understanding of the relevance and importance of corporate and public ethics on the development and marketing of medicines.
• Provide an overview of the professional standards, codes and rules impacting the pharmaceutical industry (including GxP).
• Enable students to appreciate the ethical aspects of medicine development and clinical trials (including the role and responsibilities of Ethics Committees).
• Provide the ability to appraise the range of strategies for medicine commercialisation and their ethical consequences.

Learning Outcomes

By the end of this module students will be able to:

• Review the concepts of ethics, good practice and risk/benefit in the development and marketing of medicines and how the industry is engaged to protect patients and the public.
• Create multi-national clinical and commercial development programmes that apply patient involvement and operational plans, are ethical and subscribe to GxPs.
• Critically analyse the relevant clinical and non-clinical studies that ethically justify risk/benefit.

Entry Requirements

Minimum entry requirements are either a medical degree (such as an MBBS) or a 2:1 first degree in pharmacy, pharmacology, biology, biochemistry, chemistry or related subject. The course will suit individuals seeking to develop a practical understanding of importance of ethics in medicine development and life-cycle management by the pharmaceutical industry e.g. pharmaceutical physicians, scientists in R&D and medical affairs, and regulatory affairs personnel.

Key Information

• Course code: 7BBP0013
• Credit level: 7
• Credit value: 15

Fees & Discounts

• Full Price: £1,412.00
• International: £3,975.00

Offered by

Faculty of Life Sciences & Medicine Institute of Pharmaceutical Science Centre for Pharmaceutical Medicine